Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

612 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
Eriksson BI, Carlsson S, Halvarsson M, Risberg B, Mattsson C. Eriksson BI, et al. Among authors: carlsson s. Thromb Haemost. 1997 Nov;78(5):1404-7. Thromb Haemost. 1997. PMID: 9408027
Desmopressin, surgery and thrombosis.
Mannucci PM, Carlsson S, Harris AS. Mannucci PM, et al. Among authors: carlsson s. Thromb Haemost. 1994 Jan;71(1):154-5. Thromb Haemost. 1994. PMID: 8165637 No abstract available.
Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat.
Elg M, Gustafsson D, Carlsson S. Elg M, et al. Among authors: carlsson s. Thromb Res. 1999 May 1;94(3):187-97. doi: 10.1016/s0049-3848(98)00213-8. Thromb Res. 1999. PMID: 10326765
Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.
Elg M, Carlsson S, Gustafsson D. Elg M, et al. Among authors: carlsson s. Thromb Res. 2001 Feb 1;101(3):145-57. doi: 10.1016/s0049-3848(00)00397-2. Thromb Res. 2001. PMID: 11228338
Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits.
Elg M, Carlsson S, Gustafsson D. Elg M, et al. Among authors: carlsson s. Thromb Res. 2001 Feb 1;101(3):159-70. doi: 10.1016/s0049-3848(00)00398-4. Thromb Res. 2001. PMID: 11228339
The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects.
Gustafsson D, Nyström J, Carlsson S, Bredberg U, Eriksson U, Gyzander E, Elg M, Antonsson T, Hoffmann K, Ungell A, Sörensen H, Någård S, Abrahamsson A, Bylund R. Gustafsson D, et al. Among authors: carlsson s. Thromb Res. 2001 Feb 1;101(3):171-81. doi: 10.1016/s0049-3848(00)00399-6. Thromb Res. 2001. PMID: 11228340
Effects of ximelagatran, the oral form of melagatran, in the treatment of caval vein thrombosis in conscious rats.
Carlsson S, Elg M, Mattsson C. Carlsson S, et al. Thromb Res. 2002 Aug 15;107(3-4):163-8. doi: 10.1016/s0049-3848(02)00257-8. Thromb Res. 2002. PMID: 12431484
Melagatran attenuates fibrin and platelet deposition in a porcine coronary artery over-stretch injury model.
Scherstén F, Wahlund G, Björnheden T, Carlsson S, Mattsson C, Grip L. Scherstén F, et al. Among authors: carlsson s. Blood Coagul Fibrinolysis. 2003 Apr;14(3):235-41. doi: 10.1097/01.mbc.0000061284.28953.f7. Blood Coagul Fibrinolysis. 2003. PMID: 12695745
Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis.
Sarich TC, Osende JI, Eriksson UG, Fager GB, Eriksson-Lepkowska M, Ohlsson L, Carlsson S, Wåhlander K, Gustafsson D, Badimon JJ. Sarich TC, et al. Among authors: carlsson s. J Thromb Haemost. 2003 May;1(5):999-1004. doi: 10.1046/j.1538-7836.2003.00201.x. J Thromb Haemost. 2003. PMID: 12871368 Clinical Trial.
The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model.
Klement P, Carlsson S, Rak J, Liao P, Vlasin M, Stafford A, Johnston M, Weitz JI. Klement P, et al. Among authors: carlsson s. J Thromb Haemost. 2003 Mar;1(3):587-94. doi: 10.1046/j.1538-7836.2003.00060.x. J Thromb Haemost. 2003. PMID: 12871470
612 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback